Trials / Completed
CompletedNCT05462327
Low Fresh Gas Flow in Prone Position
Low Fresh Gas Flow and Normal Gas Flow Anesthesia in Patients Undergoing Surgery in Prone Position: Impact on Hemodynamics and Regional Cerebral Oxygenation
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 46 (actual)
- Sponsor
- Prof. Dr. Cemil Tascıoglu Education and Research Hospital Organization · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
Low flow anesthesia in the prone position was safe in terms of systemic hemodynamics and did not reduce cerebral oxygenation compared to normal flow.
Detailed description
Patients were randomly allocated to either low fresh gas flow(LF, 0,5 L/min during maintenance) or normal flow (NF, 2 L/min)) general anesthesia. In both groups, participants were first administered with 100% oxygen at a 4 L/min flow rate. Propofol 2-2,5 mg/kg, rocuronium bromide 0,6 mg/kg, and fentanyl 1 mcg/kg IV were used for anesthesia induction.In the operating room, pulse rate, mean arterial pressure (MAP), peripheral hemoglobin oxygen saturation (spO2), and right and left side regional cerebral oxygen saturation (Masimo's O3 regional oximetry device) were measured before premedication and anesthesia induction, at 10 minutes after endotracheal intubation, at 10 minutes after prone positioning, at 1st, 2nd, 3rd, 4th and 5th hours of operation, before repositioning to supine, after the resumption of supine position and at 5 minutes after extubation. In conclusion, low flow anesthesia in patients undergoing surgery in the prone position did not cause a reduction in cerebral oxygenation compared to normal flow.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Low Fresh Gas Flow in Prone Position | In the low fresh gas flow group, the flow rate was reduced to 0.5 L/min |
| PROCEDURE | Normal Fresh Gas Flow in Prone Position | In the normal flow rate group, the gas flow rate was reduced to 2 L/min during the maintenance phase. |
Timeline
- Start date
- 2019-10-01
- Primary completion
- 2020-03-31
- Completion
- 2020-03-31
- First posted
- 2022-07-18
- Last updated
- 2022-07-18
Locations
1 site across 1 country: Turkey (Türkiye)
Source: ClinicalTrials.gov record NCT05462327. Inclusion in this directory is not an endorsement.